Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Lucio Tentori"'
Autor:
Maria Grazia Atzori, Lucio Tentori, Federica Ruffini, Claudia Ceci, Lucia Lisi, Elena Bonanno, Manuel Scimeca, Eskil Eskilsson, Thomas Daubon, Hrvoje Miletic, Lucia Ricci Vitiani, Roberto Pallini, Pierluigi Navarra, Rolf Bjerkvig, Stefania D’Atri, Pedro Miguel Lacal, Grazia Graziani
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-15 (2017)
Abstract Background Glioblastoma (GBM) is a highly migratory, invasive, and angiogenic brain tumor. Like vascular endothelial growth factor-A (VEGF-A), placental growth factor (PlGF) promotes GBM angiogenesis. VEGF-A is a ligand for both VEGF recepto
Externí odkaz:
https://doaj.org/article/21f609d6b22d4a21bee8c1e043aab86e
Publikováno v:
Experientia supplementum (2012). 113
The immune checkpoint cytotoxic T lymphocyte-associated antigen 4 (CTLA-4 or CD152) is a negative regulator of T-cell-mediated immune responses which plays a critical role in suppressing autoimmunity and maintaining immune homeostasis. Because of its
Publikováno v:
Experientia Supplementum ISBN: 9783030913106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45a6741b2dfe96ab1217a31679c721e4
https://doi.org/10.1007/978-3-030-91311-3_10
https://doi.org/10.1007/978-3-030-91311-3_10
Autor:
Rosella Cicconi, Grazia Graziani, Manuel Scimeca, Roberta Bernardini, Pedro Miguel Lacal, Lucio Tentori, Elena Bonanno, Maria Grazia Atzori, Federica Ruffini, Stefania D'Atri, Maurizio Mattei
The vascular endothelial growth factor receptor-1 (VEGFR-1) is a membrane receptor for VEGF-A, placenta growth factor (PlGF) and VEGF-B that plays a crucial role in melanoma invasiveness, vasculogenic mimicry and tumor-associated angiogenesis. Furthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4655779bd12726d979a3f7c3d816ee3b
http://hdl.handle.net/2108/256590
http://hdl.handle.net/2108/256590
Autor:
Paola Grimaldi, Grazia Graziani, Giovanna D'Arcangelo, Emanuela De Domenico, Lucio Tentori, Mattia Palmieri, Isabella Faraoni, Virginia Tancredi
Publikováno v:
Oncotarget
The Growth Differentiation Factor 11 (GDF11) has been controversially involved in the aging/rejuvenation process. To clarify whether GDF11 is differently expressed during aging, we have evaluated GDF11 levels in skeletal muscles and hippocampi of you
Autor:
Claudia Ceci, Maria Luisa Barbaccia, Pedro Miguel Lacal, Maria Grazia Atzori, Stefania D'Atri, Mauro Trapani, Grazia Graziani, Lucio Tentori, Federica Ruffini
Publikováno v:
Journal of Cellular and Molecular Medicine
The vascular endothelial growth factor receptor‐1 (VEGFR‐1) is a tyrosine kinase receptor frequently expressed in melanoma. Its activation by VEGF‐A or placental growth factor (PlGF) promotes tumour cell survival, migration and invasiveness. Mo
Autor:
Camilla Palumbo, Lucio Tentori, Dante Rotili, Grazia Graziani, Chiara Fulci, Francesca Sciarretta, Anna Maria Caccuri
Background: PD-L1 is a membrane protein with inhibitory effects on immune responses, whose expression has been correlated with high aggressiveness and the propensity of melanoma to metastasize. The nitrobenzoxadiazole (NBD) NBDHEX and its analog MC31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9814527f190d25b6da9b68b8f7aa0e8f
http://hdl.handle.net/2108/224878
http://hdl.handle.net/2108/224878
Autor:
Pedro Miguel Lacal, Stefania D'Atri, Veronica Morea, Cristina Maria Failla, Elena Bonanno, Manuel Scimeca, Grazia Graziani, Federica Ruffini, Maria Grazia Atzori, Annalisa Susanna Dorio, Lucio Tentori
Publikováno v:
Oncotarget
Oncotarget 7 (2016): 72868–72885. doi:10.18632/oncotarget.12108
info:cnr-pdr/source/autori:Graziani, Grazia; Ruffini, Federica; Tentori, Lucio; Scimeca, Manuel; Dorio, Annalisa S.; Atzori, Maria Grazia; Failla, Cristina M.; Morea, Veronica; Bonanno, Elena; D'Atri, Stefania; Lacal, Pedro M./titolo:Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding/doi:10.18632%2Foncotarget.12108/rivista:Oncotarget/anno:2016/pagina_da:72868/pagina_a:72885/intervallo_pagine:72868–72885/volume:7
Oncotarget 7 (2016): 72868–72885. doi:10.18632/oncotarget.12108
info:cnr-pdr/source/autori:Graziani, Grazia; Ruffini, Federica; Tentori, Lucio; Scimeca, Manuel; Dorio, Annalisa S.; Atzori, Maria Grazia; Failla, Cristina M.; Morea, Veronica; Bonanno, Elena; D'Atri, Stefania; Lacal, Pedro M./titolo:Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding/doi:10.18632%2Foncotarget.12108/rivista:Oncotarget/anno:2016/pagina_da:72868/pagina_a:72885/intervallo_pagine:72868–72885/volume:7
Vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase transmembrane receptor that has also a soluble isoform containing most of the extracellular ligand binding domain (sVEGFR-1). VEGF-A binds to both VEGFR-2 and VEGFR-1, where
Autor:
Roberto Miano, Grazia Graziani, Pedro Miguel Lacal, Maria Gabriella De Martino, Lucio Tentori, Claudia Ceci
Publikováno v:
Nutrients
Nutrients, Vol 10, Iss 11, p 1756 (2018)
Nutrients, Vol 10, Iss 11, p 1756 (2018)
Ellagic acid (EA) is a naturally occurring polyphenolic compound endowed with strong antioxidant and anticancer properties that is present in high quantity in a variety of berries, pomegranates, and dried fruits. The antitumor activity of EA has been
Publikováno v:
Oncology Reports.
The vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor activated by the angiogenic factors VEGF‑A and placental growth factor (PlGF). While VEGF‑A binds to both VEGFR‑1 and VEGFR‑2, PlGF interacts exclusivel